RSS

fined

The UK’s Competition and Markets Authority (CMA) dishes the two firms a record fine of nearly £90 million for charging excessive prices to the NHS for an anti-epilepsy drug. more

News

GlaxoSmithKline (GSK), Generics UK (GUK) and Alpharma have been fined £45m by the Competition and Markets Authority (CMA) for anti-competitive conduct and agreements more

News